Functionality of natural killer cells from end-stage cancer patients exposed to coherent electromagnetic fields

Απλή σελίδα τεκμηρίου
dc.contributor.authorEvangelou, A.en
dc.contributor.authorToliopoulos, I.en
dc.contributor.authorGiotis, C.en
dc.contributor.authorMetsios, A.en
dc.contributor.authorVerginadis, I.en
dc.contributor.authorSimos, Y.en
dc.contributor.authorHavelas, K.en
dc.contributor.authorHadziaivazis, G.en
dc.contributor.authorKarkabounas, S.en
dc.date.accessioned2015-11-24T19:15:11Z
dc.date.available2015-11-24T19:15:11Z
dc.identifier.issn1536-8378-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/21471
dc.rightsDefault Licence-
dc.subjectnatural killer cellsen
dc.subjectflow cytometryen
dc.subjectcoherent electromagnetic fieldsen
dc.subjectelectromagneticen
dc.subjectresonanceen
dc.subjectmagnetic-fieldsen
dc.subjectflow-cytometryen
dc.subjecttumor-growthen
dc.subjectwistar ratsen
dc.subjecttoxicityen
dc.subjectchemotherapyen
dc.subjectenhancementen
dc.subjectlymphocytesen
dc.subjectinhibitionen
dc.subjectsafetyen
dc.titleFunctionality of natural killer cells from end-stage cancer patients exposed to coherent electromagnetic fieldsen
heal.abstractThe main objective of our study is to investigate whether an enhancement of the immune system in end-stage cancer patients is achieved by exposure to coherent electromagnetic fields. For this reason, 15 end-stage cancer patients were exposed at low intensity, coherent electromagnetic fields at radiofrequencies ranging from 600 kHz--729 Hz, for 8 h/day, 6 days/week for 4 weeks. NKs number and cytotoxicity of NK T-lymphocytes versus K562 cancer cell line were estimated by flow cytometry, before and after exposure. Data showed that the exposure of the end-stage cancer patients to the coherent electromagnetic fields resulted in a significant increase of the number and the cytotoxicity of the NK T-lymphocytes against cancer cells, in all patients. Exposure to coherent EMFs at radiofrequencies increases the number and cytotoxicity of NK T-lymphocytes, which may contribute to the improvement of cancer patients' status.</.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primaryDoi 10.3109/15368378.2011.566776-
heal.identifier.secondary<Go to ISI>://000290408500004-
heal.identifier.secondaryhttp://informahealthcare.com/doi/abs/10.3109/15368378.2011.566776-
heal.journalNameElectromagn Biol Meden
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2011-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ